Abstract
Abstract Pediatric high-grade gliomas (pHGG) are aggressive primary brain neoplasms with a dismal prognosis, making them the leading cause of brain tumor-related deaths in children. pHGGs occur in specific anatomical locations at specific ages underscoring their origin in neurodevelopment and the critical importance of the brain tumor microenvironment. Activity-regulated mechanisms are major regulators of neural development and plasticity. Many pHGGs originate from oligodendroglial precursor cells (OPC) and, like OPCs, neuronal activity promotes pHGG proliferation. Recent work has demonstrated that pHGG cells form calcium-permeable AMPAR-mediated synapses with neurons analogous to the axo-glial synapses that form between neurons and OPCs. Neuronal activity drives pHGG growth through secretion of activity-regulated mitogens and through electrochemical communication with pHGG cells that integrate into neural circuits. In turn, pHGG increases neuronal excitability and remodels functional neural circuits. The interconnected network of glioma cells and neurons is fundamental to pHGG progression. However, how these neuron-glioma networks evolve over time remains to be fully understood. We hypothesize that as gliomas progress, the neuron-glioma malignant circuitry evolves chiefly through synaptogenesis to promote activity that fosters glioma progression. Thus, we developed a two-color in vivo imaging method to study neuron-glioma cell interactions over time in freely behaving mice enabling us to record the frequency, pattern, and synchronicity of calcium transients in neurons, glioma cells, and their coactivity giving us a comprehensive view of the changes in neuron-glioma circuit dynamics over time. We have observed increasing neuronal activity throughout the disease, consistent with increasing neural hyperexcitability over time, and have observed that different types of gliomas exhibit unique patterns of calcium transients (rise time, peak amplitude, decay time, and half-width). Our imaging paradigm offers a unique ability to study neuron-glioma interactions at the systems level and will allow us to study how pharmacological inhibitors and neuronal experience shape neuron-glioma malignant circuit dynamics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.